Key result
Valve repair during concomitant tricuspid annuloplasty was feasible in 12% of patients with rheumatic mitral valve disease compared to 52% with degenerative mitral valve disease.
Answers are grounded in this paper and cite their sources.
Mitral valve repair is significantly more feasible in patients with degenerative compared to rheumatic mitral valve disease undergoing concomitant tricuspid annuloplasty.
The article published in this edition of Journal of Cardiac Surgery, Arafat and colleagues discuss the results of their ten year clinical experience of concomitant tricuspid annuloplasty (TA) for moderate to severe tricuspid regurgitation (TR) during mitral valve surgery in patients with rheumatic (RMVD - n= 345; 61% had mitral regurgitation and 39% mitral valve stenosis) and degenerative (DMVD n= 135) mitral valve diseases, The objective of the observational non-randomized trial was to identify predictors of durability of TA for moderate to severe TR in patients with RMVD and DMVD undergoing mitral valve repairs and replacements. Valve repair was feasible in 12% in the RMVD group as compared to 52% in DMVD group (1). The TA was performed with flexible, rigid prostheses and the de Vega suture technique.
No takes yet. Share an insight, caveat, or question.
Yankah et al. (2024) conducted an editorial in Moderate to severe tricuspid regurgitation and mitral valve disease (n=480). Rheumatic mitral valve disease (RMVD) vs. Degenerative mitral valve disease (DMVD) was evaluated on Feasibility of valve repair. Valve repair during concomitant tricuspid annuloplasty was feasible in 12% of patients with rheumatic mitral valve disease compared to 52% with degenerative mitral valve disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: